NEW YORK (GenomeWeb News) – Agilent Technologies will co-market CambTEK's extraction and sample prep technologies with its own liquid phase separation, life science, and chemical analysis instruments and software, the companies said today.

Under the agreement, the partners will co-market CambTEK's Rapid Extraction System (RES) for automated sample preparation alongside the Agilent instruments and software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.